Ataxia-telangiectasia is an autosomal recessive condition characterized by progressive cerebellar ataxia and oculocutaneous telangiectasias.

A 6-year-old girl was seen for evaluation of recurrent sinus infection. Her parents also were concerned about her progressively unsteady gait and frequent falls.

Key points: Based on clinical findings of ataxia and ocular telangiectasia (Figure 1, top) the patient was given a diagnosis of ataxia-telangiectasia (A-T). Screening for serum alpha-fetoprotein, a marker for A-T, found a concentration of 660 ng/mL (normal, <8 ng/mL). A subsequent MRI study of the brain showed marked cerebellar atrophy (Figure 2, bottom).

A-T, also known as Louis-Bar syndrome, is an autosomal recessive condition characterized by progressive cerebellar ataxia, oculocutaneous

telangiectasias, recurrent sinopulmonary disease, variable humoral and cellular immunodeficiency, and a high incidence of malignancy.

Management: There is no definitive treatment available. Recurrent sinopulmonary infections are common in most patients; immunoglobulin replacement therapy may decrease these and other infections, which can be severe. Aggressive pulmonary hygiene is recommended for patients with chronic bronchiectasis. Patients have increased sensitivity to ionizing radiation; diagnostic procedures such as X-ray and CT scans, therefore, should be limited.

Note: Ataxia usually becomes apparent by 2 years of age. It is progressive and most children with A-T are wheelchair-bound by 10 to 12 years of age. Ocular telangiectasia is not usually seen until approximately 3 to 6 years of age.


Related Videos
Angela Nash, PhD, APRN, CPNP-PC, PMHS | Image credit: UTHealth Houston
Allison Scott, DNP, CPNP-PC, IBCLC
Joanne M. Howard, MSN, MA, RN, CPNP-PC, PMHS & Anne Craig, MSN, RN, CPNP-PC
Juanita Mora, MD
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
© 2024 MJH Life Sciences

All rights reserved.